Italia markets open in 2 hours 29 minutes

Wave Life Sciences Ltd. (WVE)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
5,08+0,24 (+4,96%)
Alla chiusura: 04:00PM EDT
5,33 +0,25 (+5,00%)
Dopo ore: 06:45PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente4,84
Aperto5,14
Denaro5,02 x 100
Lettera5,13 x 100
Min-Max giorno5,00 - 5,18
Intervallo di 52 settimane3,15 - 7,67
Volume450.738
Media Volume904.425
Capitalizzazione621,203M
Beta (5 anni mensile)-1,08
Rapporto PE (ttm)N/D
EPS (ttm)-0,54
Prossima data utili01 mag 2024 - 06 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A13,00
  • GlobeNewswire

    Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day

    Presented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including obesity, which uses Wave’s best-in-class GalNAc-siRNA capabilities and novel genetic insights from GSK WVE-006 – industry’s first-ever RNA editing clinical candidate – on track for dosing in RestorAATion clinical trial in 4Q 2023 and first human proof-of-mechanism data in 2024 Advancing multiple, wholly owned RNA editing targets using correction and upregulation approaches

  • GlobeNewswire

    Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference

    CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan 7th Annual Genetic Medicines Conference in New York City on Monday, October 2, 2023. Dr. Bolno will participate in the ADAR Editing Panel at 9:30 a.m. ET and

  • GlobeNewswire

    Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference

    CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in a virtual analyst-led fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference. The presentation will be available to view beginning on Monday, S